General
Preferred name
BETHANIDINE
Synonyms
betanidine ()
Bethanidine iodide ()
BETHANIDINE SULFATE ()
Betanidina ()
Esbatal ()
Bethanidine sulphate ()
Bendogen ()
Betanidine sulphate ()
Betanidine Sulfate ()
NSC-106563 ()
Tenathan ()
BW-467-C-60 ()
P&D ID
PD010167
CAS
55-73-2
2863-34-5
Tags
available
drug
Approved by
FDA
Drug indication
Hypertension
Heart arrhythmia
Drug Status
approved
withdrawn
Max Phase
4.0
First approval
1982
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Betanidine is a guanidinium-based sympatholytic antihypertensive drug.
(GtoPdb)
DESCRIPTION
Bethanidine is a guanidinium antihypertensive agent that acts by blocking adrenergic transmission.
(Enamine Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
14
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
NPC Screening Collection
ReFrame library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
38
Molecular Weight
177.13
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
0.98
TPSA
36.42
Fraction CSP3
0.3
Chiral centers
0.0
Largest ring
6.0
QED
0.52
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
ATC
C02CC01
Therapeutic Class
Antihypertensive Agents
Source data

